Close

Analyst Ratings for Immunovant (IMVT)

IMVT Rating Summary

IMVT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IMVT
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $15.25 (-13.9%) * Over Last 12-Mos
Rating Score: 4.5 / 10   Percentile Rank: 44%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/3/2023 Wells Fargo Chris M. Carey Upgrade Overweight
(Equal Weight)
27.00
(10.00)
17.41
(17.72)
1.78% Details
9/26/2022 UBS Colin Bristow Downgrade Neutral
(Buy)
5.00
(7.00)
5.13
(17.72)
245.42% Details